Rekvina Laboratories Board Meeting on Aug 13 to Approve Unaudited Results

Rekvina Laboratories Ltd has announced that its Board of Directors will convene on August 13, 2026, to consider and approve the Unaudited Standalone Financial Results for the quarter ending June 30, 2026, prepared under Indian Accounting Standards (Ind AS). The company has also informed its designated persons about the closure of the trading window for company shares from July 01, 2026, until 48 hours after the financial results are publicly disclosed, in compliance with SEBI regulations on insider trading.